American Clinical Laboratory Association

In 2014, Congress passed the Protecting Access to Medicare Act (PAMA) to reform payment to clinical laboratories under the Clinical Laboratory Fee Schedule (CLFS). CMS’s flawed implementation led to rates that fail to reflect private payer rates as intended, years of payment cuts, and a lack of recognition of rising inflation. ACLA urges Congress to protect access to quality laboratory diagnostics and services by enacting long-term PAMA reform through the Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act.

Learn More

ACLA’s 2026 advocacy agenda demonstrates the association’s commitment to advancing policy in the areas of reimbursement, regulation, infrastructure for preparedness and response, innovation, and public affairs. The advocacy agenda summarizes our goals to expand access to the highest quality clinical laboratory services, improve patient outcomes, and advance the next generation of personalized care.

Accurate, reliable test results help provide a complete picture of health and align all players in the health system towards patient-centered care.